Bespoke solutions for lead selection and optimization in cancer antibody research

At evitria, we are specialized in transient transfection of CHO cells to produce recombinant antibodies. Find out more about our approach in this article.

Both transient and stable transfection are essential methods in genetic engineering. But what are the differences between them? Let’s find out in this article.

Transient transfection offers numerous advantages in the expression of recombinant proteins. We will uncover the main benefits in this article.

At evitria, we are specialized in transient transfection of CHO cells to produce recombinant antibodies. Find out more about our approach in this article.

Both transient and stable transfection are essential methods in genetic engineering. But what are the differences between them? Let’s find out in this article.

Transient transfection offers numerous advantages in the expression of recombinant proteins. We will uncover the main benefits in this article.

The term “in vivo antibodies” is somewhat ambiguous, as it can describe both antibodies that are produced in vivo and those that are designed for in vivo applications. Both aspects will be discussed in this article.

Antibody production is performed in a set of distinctive steps, requiring expert knowledge and devices. In this article, we will take a look at these individual steps and highlight some challenges and considerations.